Phage display remains the most widely used antibody discovery method owing to its versatility, robustness, applicability, and ...

At the heart of the Pioneer Antibody Discovery Platform is the Pioneer Antibody Library ... For example, we have an antibody library for generating drug candidates (Pioneer), such as therapeutic ...

The initial antibody sequence is then passed through ... AI-small molecule discovery spaces Compared to the small molecule AI drug discovery ecosystem, this space is evolving differently.

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...

“AMD high-performance compute will enable us to further the development of next-generation antibody therapeutics ... to accelerate the future of drug discovery,” Absci Chief Executive Sean ...

Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of anti-dengue virus antibody: Tokyo Friday, January 31, 2025, 09:00 Hrs [IST] Chugai Phar ...

Various antibody candidates will then be screened ... said that IBM “share our vision of making in silico biologic drug discovery a reality.” Earlier this year, the German pharma company ...

Their approach involves combining proprietary 3D modeling with drug discovery platforms to create breakthrough antibody treatments.

SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, in ...